• AMAG Pharmaceuticals Inc., of Lexington, Mass., reported total revenues for the third quarter of $17.7 million, falling short of analyst estimates of $20.4 million. Revenue included $16.2 million in net U.S. sales for iron deficiency product Feraheme (fermuoxytol), which increased over the second quarter of 2012 due to improved pricing dynamics.
Suite: 1100 | Atlanta, Georgia 30346, USA
In the U.S. and Canada: 1-855-260-5607
Outside the U.S.: 1-646-822-4549
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter